• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

DOI: 10.12201/bmr.202601.00059
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: [abstract missed]

    Key words: ; ; 

    Submit time: 20 January 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • ZHANG Haiou. . 2026. doi: 10.12201/bmr.202602.00042

    NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006

    XIONG Yan, ZHANGT Tao. Exploring Professor Xiong Yan. 2025. doi: 10.12201/bmr.202509.00053

    王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018

    Chen Zhiyun. Effects of common environmental pollutants on non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202506.00049

    YAO Junxiao, WANG Lianzi, ZANG Yan, SHEN Mengjiao, LI Tao▲. Association Between Lipoprotein-to-Uric Acid Ratios and Nonalcoholic Fatty Liver Disease in Newly Diagnosed Type 2 Diabetes Patients. 2025. doi: 10.12201/bmr.202512.00017

    Xiaozhihong. . 2025. doi: 10.12201/bmr.202509.00057

    李丹, liang xuan, li wenlong. . 2026. doi: 10.12201/bmr.202601.00044

    ZHU WENLIN, SUN YUNYUN, ZHANG JUN. . 2025. doi: 10.12201/bmr.202507.00062

    HU Fangzhu, PAN Jiang. . 2025. doi: 10.12201/bmr.202509.00068

  • ID Submit time Number Download
    1 2026-01-05

    10.12201/bmr.202601.00059V1

    Download
  • Public  Anonymous  To author only

Get Citation

ZhouQintian, LiJie, LinPing, ShaoYanfeng. [title missed]. 2026. biomedRxiv.202601.00059

Article Metrics

  • Read: 141
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误